ADAR1 Capital Management’s iBio IBIO Stock Holding History

ADAR1 Capital Management’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$657K	Sell	375,531 -94,347	-20%	-$169K	0.03%	192
2026 Q1	$893K	Buy	469,878 +64,347	+16%	+$149K	0.05%	171
2025 Q4	$783K	Buy	405,531 +378,531	+1,402%	+$517K	0.06%	153
2025 Q3	$22.4K	Sell	27,000 -27,819	-51%	-$21.4K	﹤0.01%	212
2025 Q2	$41.8K	Buy	+54,819	New	+$59.5K	0.01%	193
2025 Q1	–	Sell	-415,606	Closed	-$1.02M	–	229
2024 Q4	$1.02M	Sell	415,606 -60,606	-13%	-$156K	0.2%	75
2024 Q3	$1.06M	Sell	476,212 -93,788	-16%	-$185K	0.17%	71
2024 Q2	$1.2M	Sell	570,000 -30,000	-5%	-$64.5K	0.23%	59
2024 Q1	$2.19M	Buy	+600,000	New	+$754K	0.5%	39

Other funds holding IBIO

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.65% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

ADAR1 Capital Management's IBIO Position: Q2 2026 in Review

ADAR1 Capital Management reduced its iBio (IBIO) stake by 20% in Q2 2026, selling an estimated $169K and leaving 375,531 shares worth $657K. The position accounts for 0.03% of the portfolio, ranked #192.

ADAR1 Capital Management first reported a position in IBIO in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.19M in Q1 2024. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

ADAR1 Capital Management held 375,531 shares of iBio worth $657K as of Q2 2026.
ADAR1 Capital Management sold 94,347 iBio shares in Q2 2026, an estimated $169K.
iBio made up 0.03% of ADAR1 Capital Management's portfolio in Q2 2026, its #192 holding.
ADAR1 Capital Management first reported a position in iBio in Q1 2024 and has held it in 9 quarters since.
ADAR1 Capital Management's iBio position peaked at $2.19M in Q1 2024.
55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.